This study aims to decipher the role of RARγ isoforms in carcinogenesis and progression of HNC, and to explore the feasibility of RARγ-targeting approach as a therapeutic and/or chemo-preventive strategy for HNC and other types of human cancers. Here, RARG is linked to cancer.